PNTG vs. SHC, SGRY, PRVA, CON, LFST, WGS, VCYT, ARDT, ADUS, and PGNY
Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), GeneDx (WGS), Veracyte (VCYT), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), and Progyny (PGNY). These companies are all part of the "healthcare" industry.
The Pennant Group vs. Its Competitors
Sotera Health (NASDAQ:SHC) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation.
Sotera Health received 10 more outperform votes than The Pennant Group when rated by MarketBeat users. Likewise, 58.24% of users gave Sotera Health an outperform vote while only 46.24% of users gave The Pennant Group an outperform vote.
Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.
91.0% of Sotera Health shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 47.5% of Sotera Health shares are held by company insiders. Comparatively, 5.4% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Sotera Health has a net margin of 6.31% compared to The Pennant Group's net margin of 3.24%. Sotera Health's return on equity of 42.27% beat The Pennant Group's return on equity.
Sotera Health has a beta of 1.87, suggesting that its share price is 87% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500.
In the previous week, Sotera Health had 2 more articles in the media than The Pennant Group. MarketBeat recorded 8 mentions for Sotera Health and 6 mentions for The Pennant Group. Sotera Health's average media sentiment score of 0.99 beat The Pennant Group's score of 0.87 indicating that Sotera Health is being referred to more favorably in the media.
Sotera Health presently has a consensus target price of $15.80, indicating a potential upside of 34.13%. The Pennant Group has a consensus target price of $34.60, indicating a potential upside of 26.60%. Given Sotera Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Sotera Health is more favorable than The Pennant Group.
Summary
Sotera Health beats The Pennant Group on 17 of the 18 factors compared between the two stocks.
Get The Pennant Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Pennant Group Competitors List
Related Companies and Tools
This page (NASDAQ:PNTG) was last updated on 6/12/2025 by MarketBeat.com Staff
